The expression level of IL-17 is higher in DTC and MTC than that in benign thyroid neoplasms (36), which suggests that IL-17 is closely correlated to the aggressiveness of thyroid cancer, and the tumor pro-angiogenesis of IL-17 could have roles in this process. This evidence concerns the gene IL17A and medullary thyroid gland carcinoma.